60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.82M
Last updated: Nov 17, 2026 at 11:05 AM ET
60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) Stock Forecast
Analysts expect 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) to earn -$3.45 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.00M. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$3.58.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates rise 70.0%.
- Fiscal year ending Dec 31, 2026
- -$3.45
- EPS consensus, revenue $1.00M
- Fiscal year ending Dec 31, 2027
- -$3.58
- EPS consensus, revenue $1.70M
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$3.45 | -$3.45 to -$3.45 | 1 | $1.00M | $1.00M to $1.00M | 2 |
| Dec 31, 2027 | -$3.58 | -$3.58 to -$3.58 | 1 | $1.70M | $1.40M to $2.00M | 2 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.80 | -$0.87 to -$0.70 | 4 | $311100 | $294000 to $325500 | 4 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 0 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$7.88.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$3.45 | -$3.18 | -$3.18 | -$7.88 | -$7.88 | N/A |
Frequently Asked Questions About SXTP
What is the SXTP stock forecast?
Consensus analyst estimates put 60 Degrees Pharmaceuticals, Inc. Common Stock's EPS at -$3.45 for the fiscal year ending Dec 31, 2026, on revenue of $1.00M.
What EPS do analysts expect from SXTP next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$3.45, with estimates from -$3.45 to -$3.45 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$3.58, with estimates from -$3.58 to -$3.58 from 1 analyst.
What revenue do analysts expect from 60 Degrees Pharmaceuticals, Inc. Common Stock next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.00M, with estimates from $1.00M to $1.00M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.70M, with estimates from $1.40M to $2.00M.
How many analysts cover SXTP?
1 analyst estimates EPS for 60 Degrees Pharmaceuticals, Inc. Common Stock for the fiscal year ending Dec 31, 2026.
SXTP pages: Overview, Earnings, Forecast, Financials, Competitors